Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 12 | 2,686 | 1,653 | 408 | 669 |
| Gross Profit | 12 | 2,686 | 1,653 | 408 | 669 |
| Operating Expenses | 6,881 | 9,795 | 12,497 | 14,967 | 14,016 |
| Operating Income | -6,869 | -7,109 | -10,845 | -14,559 | -13,347 |
| Interest Expense | 4 | 0 | 1 | 1 | 0 |
| Other Income | 23 | 108 | 120 | 1 | 4 |
| Pre-tax Income | -6,850 | -7,001 | -10,725 | -14,560 | -13,343 |
| Income Tax | 12 | 95 | 86 | -1,342 | N/A |
| Net Income Continuous | -6,862 | -7,097 | -10,811 | -13,218 | -13,343 |
| Net Income | $-6,862 | $-7,097 | $-10,811 | $-13,218 | $-13,343 |
| EPS Basic Total Ops | -536.45 | -802.88 | -1,645.37 | -5,019.99 | -8,150.74 |
| EPS Basic Continuous Ops | -538.11 | -803.23 | -1,645.18 | -5,003.38 | -8,153.24 |
| EPS Diluted Total Ops | -536.45 | -802.88 | -1,645.37 | -5,019.99 | -8,150.74 |
| EPS Diluted Continuous Ops | -538.11 | -803.23 | -1,645.18 | -5,003.38 | -8,153.24 |
| EPS Diluted Before Non-Recurring Items | -637.26 | -802.88 | N/A | N/A | N/A |
| EBITDA(a) | $-6,836 | $-7,057 | $-10,806 | $-14,540 | $-13,342 |